BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
The influence of <i>Azadirachta indica</i>, <i>Melaleuca alternifolia</i>, and <i>Cocos nucifera</i> on <i>Candida albicans</i> strain in tissue conditioner at varying time intervals. ✅
Go to Publication ✅
Journal of Indian Prosthodontic Society (J Indian Prosthodont Soc ) Vol: 20 Issue 2 Pages: 171-179 Pub: 2020 Apr-Jun Epub: 2020 Apr 7 Authors Kumar PS , |
|
|
Next generation sequencing of oral microbiota in Type 2 diabetes mellitus prior to and after neem stick usage and correlation with serum monocyte chemoattractant-1. ✅
Go to Publication ✅
Diabetes research and clinical practice (Diabetes Res Clin Pract ) Vol: 130 Issue Pages: 204-210 Pub: 2017 Aug Epub: 2017 Jun 13 Authors Anbalagan R , Srikanth P , Mani M , Barani R , Seshadri KG , Janarthanan R , |
|
|
In vitro antimicrobial and cytotoxic activity of Neem and Kirata herbal formulation mediated Silver nanoparticles. ✅
Go to Publication ✅
Bioinformation (Bioinformation ) Vol: 18 Issue 11 Pages: 1069-1074 Pub: 2022 Epub: 2022 Nov 30 Authors R R , Sp SD , B N , S R , |
|
|
Assessment of Antimicrobial Effectiveness of Neem and Clove Extract Against Streptococcus mutans and Candida albicans: An In vitro Study. ✅
Go to Publication ✅
Nigerian medical journal : journal of the Nigeria Medical Association (Niger Med J ) Vol: 60 Issue 6 Pages: 285-289 Pub: 2019 Nov-Dec Epub: 2020 Feb 24 Authors Bansal V , Gupta M , Bhaduri T , Shaikh SA , Sayed FR , Bansal V , Agrawal A , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
